Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Adipocytes | 23 | 2015 | 162 | 3.980 |
Why?
|
Glycogen | 17 | 2016 | 59 | 3.540 |
Why?
|
Obesity | 14 | 2022 | 964 | 2.310 |
Why?
|
Adipose Tissue | 10 | 2020 | 259 | 1.890 |
Why?
|
Insulin Resistance | 8 | 2019 | 353 | 1.760 |
Why?
|
Glycogen Synthase | 12 | 2016 | 22 | 1.390 |
Why?
|
Insulin | 17 | 2013 | 1146 | 1.360 |
Why?
|
Bariatric Surgery | 3 | 2019 | 195 | 1.350 |
Why?
|
Intracellular Signaling Peptides and Proteins | 8 | 2016 | 387 | 1.190 |
Why?
|
Glucose | 14 | 2014 | 628 | 1.060 |
Why?
|
Weight Loss | 3 | 2019 | 225 | 1.040 |
Why?
|
Circadian Rhythm | 2 | 2019 | 304 | 1.010 |
Why?
|
Lipid Metabolism | 6 | 2013 | 199 | 0.970 |
Why?
|
Protein Phosphatase 1 | 8 | 2010 | 34 | 0.960 |
Why?
|
Adipogenesis | 3 | 2009 | 39 | 0.920 |
Why?
|
Liver | 5 | 2013 | 1204 | 0.890 |
Why?
|
Energy Metabolism | 7 | 2022 | 276 | 0.870 |
Why?
|
Fructose | 2 | 2022 | 36 | 0.860 |
Why?
|
Mice | 37 | 2022 | 11722 | 0.810 |
Why?
|
Endocrine System | 2 | 2013 | 17 | 0.800 |
Why?
|
Phosphoprotein Phosphatases | 9 | 2016 | 58 | 0.770 |
Why?
|
Animals | 51 | 2022 | 27272 | 0.760 |
Why?
|
Glycogenolysis | 2 | 2010 | 2 | 0.700 |
Why?
|
Gene Expression | 5 | 2019 | 1309 | 0.690 |
Why?
|
Real-Time Polymerase Chain Reaction | 3 | 2019 | 282 | 0.690 |
Why?
|
Incretins | 1 | 2019 | 14 | 0.670 |
Why?
|
Bone Remodeling | 1 | 2019 | 24 | 0.670 |
Why?
|
Gonadal Steroid Hormones | 1 | 2019 | 51 | 0.660 |
Why?
|
Eating | 3 | 2022 | 165 | 0.660 |
Why?
|
Diet | 1 | 2022 | 442 | 0.650 |
Why?
|
Bone and Bones | 1 | 2019 | 269 | 0.600 |
Why?
|
Adiposity | 2 | 2017 | 76 | 0.570 |
Why?
|
Adipose Tissue, Brown | 2 | 2016 | 86 | 0.560 |
Why?
|
Uncoupling Protein 1 | 1 | 2016 | 38 | 0.550 |
Why?
|
Starvation | 1 | 2016 | 23 | 0.540 |
Why?
|
Receptors, Glucocorticoid | 3 | 2015 | 131 | 0.530 |
Why?
|
Gene Expression Profiling | 2 | 2019 | 1428 | 0.530 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2016 | 108 | 0.530 |
Why?
|
Mammary Glands, Animal | 5 | 2020 | 80 | 0.510 |
Why?
|
Aniline Compounds | 2 | 2013 | 58 | 0.500 |
Why?
|
Endocrine Disruptors | 2 | 2013 | 27 | 0.500 |
Why?
|
3T3-L1 Cells | 8 | 2013 | 34 | 0.500 |
Why?
|
Insulin Receptor Substrate Proteins | 3 | 2013 | 55 | 0.490 |
Why?
|
Sleep Deprivation | 2 | 2013 | 137 | 0.490 |
Why?
|
Diet, High-Fat | 4 | 2020 | 117 | 0.480 |
Why?
|
Thermogenesis | 2 | 2013 | 41 | 0.460 |
Why?
|
Mice, Inbred C57BL | 10 | 2022 | 3202 | 0.460 |
Why?
|
Adipose Tissue, White | 1 | 2013 | 23 | 0.440 |
Why?
|
Growth Hormone | 1 | 2013 | 96 | 0.440 |
Why?
|
Leptin | 7 | 2022 | 102 | 0.440 |
Why?
|
Catecholamines | 1 | 2013 | 91 | 0.440 |
Why?
|
Sulfonamides | 2 | 2013 | 317 | 0.430 |
Why?
|
Receptor, Insulin | 3 | 2012 | 54 | 0.420 |
Why?
|
Dioxins | 1 | 2012 | 1 | 0.420 |
Why?
|
Phosphoenolpyruvate Carboxylase | 1 | 2012 | 2 | 0.420 |
Why?
|
Polychlorinated Biphenyls | 1 | 2012 | 7 | 0.420 |
Why?
|
Phosphorylation | 9 | 2016 | 1128 | 0.410 |
Why?
|
Triglycerides | 2 | 2010 | 232 | 0.410 |
Why?
|
Models, Biological | 5 | 2016 | 1763 | 0.400 |
Why?
|
Signal Transduction | 12 | 2019 | 3370 | 0.390 |
Why?
|
Adrenal Gland Neoplasms | 2 | 2009 | 81 | 0.390 |
Why?
|
Thyroid Hormones | 1 | 2013 | 328 | 0.370 |
Why?
|
Fatty Acids | 4 | 2018 | 134 | 0.370 |
Why?
|
Hepatocytes | 6 | 2012 | 119 | 0.360 |
Why?
|
Muscle, Skeletal | 4 | 2008 | 465 | 0.360 |
Why?
|
Mice, Transgenic | 10 | 2018 | 1573 | 0.360 |
Why?
|
Liver Glycogen | 1 | 2009 | 5 | 0.340 |
Why?
|
Sleep Wake Disorders | 1 | 2010 | 116 | 0.330 |
Why?
|
Protein Transport | 3 | 2013 | 421 | 0.310 |
Why?
|
Cells, Cultured | 11 | 2021 | 2879 | 0.310 |
Why?
|
Humans | 31 | 2022 | 88835 | 0.290 |
Why?
|
Glycogen Phosphorylase | 4 | 2016 | 6 | 0.290 |
Why?
|
11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2007 | 3 | 0.290 |
Why?
|
Carcinogenesis | 2 | 2020 | 211 | 0.280 |
Why?
|
Positron-Emission Tomography | 1 | 2009 | 336 | 0.280 |
Why?
|
Diabetes Mellitus, Type 2 | 5 | 2014 | 1174 | 0.280 |
Why?
|
Triple Negative Breast Neoplasms | 2 | 2020 | 152 | 0.280 |
Why?
|
Hypoglycemic Agents | 3 | 2005 | 348 | 0.270 |
Why?
|
Male | 22 | 2021 | 42127 | 0.260 |
Why?
|
Chelating Agents | 1 | 2005 | 69 | 0.260 |
Why?
|
Organometallic Compounds | 2 | 2005 | 134 | 0.250 |
Why?
|
Dietary Fats | 2 | 2017 | 135 | 0.240 |
Why?
|
3T3 Cells | 5 | 2009 | 97 | 0.240 |
Why?
|
Macrophages | 3 | 2020 | 570 | 0.240 |
Why?
|
Mammary Neoplasms, Experimental | 2 | 2016 | 125 | 0.230 |
Why?
|
Mammary Neoplasms, Animal | 3 | 2020 | 57 | 0.220 |
Why?
|
Peptide Elongation Factor 2 | 1 | 2003 | 6 | 0.220 |
Why?
|
Weight Gain | 2 | 2022 | 119 | 0.220 |
Why?
|
Gene Expression Regulation | 7 | 2020 | 1974 | 0.220 |
Why?
|
Phosphoproteins | 1 | 2004 | 260 | 0.220 |
Why?
|
Proto-Oncogene Proteins c-akt | 4 | 2013 | 340 | 0.220 |
Why?
|
Fasting | 3 | 2013 | 163 | 0.220 |
Why?
|
Dose-Response Relationship, Drug | 5 | 2012 | 1938 | 0.210 |
Why?
|
Hunger | 1 | 2022 | 23 | 0.210 |
Why?
|
Mesentery | 2 | 2020 | 45 | 0.210 |
Why?
|
Lactic Acid | 3 | 2012 | 92 | 0.200 |
Why?
|
Nerve Growth Factors | 2 | 1993 | 63 | 0.200 |
Why?
|
Adipokines | 2 | 2019 | 17 | 0.200 |
Why?
|
Overweight | 1 | 2022 | 119 | 0.200 |
Why?
|
Serum Albumin | 1 | 2002 | 127 | 0.190 |
Why?
|
Gluconeogenesis | 3 | 2012 | 14 | 0.190 |
Why?
|
Laminin | 1 | 2021 | 89 | 0.190 |
Why?
|
Bacterial Translocation | 1 | 2020 | 26 | 0.190 |
Why?
|
Carrier Proteins | 2 | 2006 | 680 | 0.180 |
Why?
|
Diet, Fat-Restricted | 2 | 2018 | 30 | 0.180 |
Why?
|
Inflammation | 3 | 2015 | 969 | 0.180 |
Why?
|
Female | 16 | 2021 | 45893 | 0.180 |
Why?
|
Needle-Exchange Programs | 1 | 2020 | 18 | 0.180 |
Why?
|
Adenosine Triphosphate | 3 | 2012 | 315 | 0.170 |
Why?
|
Arteries | 1 | 2020 | 180 | 0.170 |
Why?
|
Gene Silencing | 3 | 2010 | 178 | 0.170 |
Why?
|
Reference Standards | 1 | 2019 | 144 | 0.170 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2020 | 113 | 0.160 |
Why?
|
Fertility | 1 | 2019 | 116 | 0.160 |
Why?
|
Protein Subunits | 3 | 2009 | 123 | 0.160 |
Why?
|
Energy Intake | 2 | 2022 | 97 | 0.160 |
Why?
|
Rats | 7 | 2018 | 4039 | 0.160 |
Why?
|
Young Adult | 4 | 2021 | 6271 | 0.160 |
Why?
|
Cell Differentiation | 6 | 2018 | 1521 | 0.160 |
Why?
|
Adenoviridae | 4 | 2010 | 349 | 0.160 |
Why?
|
Dietary Sugars | 1 | 2018 | 8 | 0.150 |
Why?
|
Proton Magnetic Resonance Spectroscopy | 1 | 2018 | 12 | 0.150 |
Why?
|
Bone Density | 1 | 2019 | 209 | 0.150 |
Why?
|
Hepatitis C | 1 | 2020 | 170 | 0.150 |
Why?
|
Magnetic Resonance Angiography | 1 | 2020 | 271 | 0.150 |
Why?
|
Feeding Behavior | 1 | 2020 | 326 | 0.150 |
Why?
|
Mutation | 1 | 2009 | 4121 | 0.150 |
Why?
|
Epithelial Cells | 3 | 2018 | 688 | 0.150 |
Why?
|
Adult | 9 | 2022 | 26437 | 0.140 |
Why?
|
Enzyme Activation | 4 | 2005 | 698 | 0.140 |
Why?
|
Binding Sites | 2 | 2010 | 1113 | 0.140 |
Why?
|
Tissue Distribution | 3 | 2006 | 292 | 0.140 |
Why?
|
Obesity, Morbid | 1 | 2019 | 233 | 0.140 |
Why?
|
PPAR gamma | 2 | 2009 | 73 | 0.140 |
Why?
|
CLOCK Proteins | 1 | 2016 | 15 | 0.140 |
Why?
|
Rats, Wistar | 4 | 2012 | 302 | 0.140 |
Why?
|
Protein Binding | 4 | 2015 | 1484 | 0.140 |
Why?
|
Oncogene Protein v-akt | 1 | 2016 | 21 | 0.140 |
Why?
|
Lipolysis | 2 | 2013 | 23 | 0.140 |
Why?
|
Lung Neoplasms | 1 | 2009 | 2344 | 0.130 |
Why?
|
Glucocorticoids | 2 | 2009 | 356 | 0.130 |
Why?
|
Toluidines | 2 | 2013 | 18 | 0.130 |
Why?
|
Subcutaneous Fat | 1 | 2015 | 22 | 0.130 |
Why?
|
Lysophospholipids | 1 | 2016 | 66 | 0.130 |
Why?
|
Glucose Tolerance Test | 2 | 2013 | 227 | 0.130 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 3 | 2002 | 86 | 0.130 |
Why?
|
Nuclear Receptor Co-Repressor 2 | 3 | 2010 | 24 | 0.130 |
Why?
|
Treatment Outcome | 2 | 2019 | 8177 | 0.120 |
Why?
|
Rats, Sprague-Dawley | 3 | 2018 | 1236 | 0.120 |
Why?
|
Up-Regulation | 3 | 2021 | 727 | 0.120 |
Why?
|
Stress, Psychological | 1 | 2018 | 321 | 0.120 |
Why?
|
Transcription Factor 7-Like 2 Protein | 1 | 2014 | 29 | 0.120 |
Why?
|
Glucose Intolerance | 1 | 2014 | 94 | 0.120 |
Why?
|
Tyrosine | 2 | 2022 | 133 | 0.120 |
Why?
|
Gastrointestinal Microbiome | 1 | 2020 | 501 | 0.110 |
Why?
|
Calmodulin-Binding Proteins | 1 | 1993 | 21 | 0.110 |
Why?
|
Stem Cells | 2 | 2020 | 372 | 0.110 |
Why?
|
Pituitary Gland | 1 | 2013 | 119 | 0.110 |
Why?
|
NADPH Oxidases | 1 | 2013 | 82 | 0.110 |
Why?
|
Disease Models, Animal | 5 | 2021 | 2347 | 0.110 |
Why?
|
Social Isolation | 1 | 2013 | 67 | 0.110 |
Why?
|
Protein Kinases | 2 | 1993 | 213 | 0.110 |
Why?
|
Glucose-6-Phosphatase | 1 | 2012 | 8 | 0.100 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2012 | 16 | 0.100 |
Why?
|
Mitochondria, Liver | 1 | 2012 | 28 | 0.100 |
Why?
|
Inflammation Mediators | 1 | 2013 | 153 | 0.100 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2012 | 71 | 0.100 |
Why?
|
Glutathione Transferase | 2 | 2009 | 112 | 0.100 |
Why?
|
Phosphatidylinositol 3-Kinase | 1 | 2012 | 14 | 0.100 |
Why?
|
Polysomnography | 1 | 2012 | 150 | 0.100 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 887 | 0.100 |
Why?
|
Flavonoids | 1 | 2012 | 87 | 0.100 |
Why?
|
Cross-Over Studies | 1 | 2012 | 389 | 0.100 |
Why?
|
Biomarkers | 2 | 2020 | 1751 | 0.100 |
Why?
|
Recombinant Fusion Proteins | 3 | 2009 | 565 | 0.100 |
Why?
|
Fatty Acid-Binding Proteins | 2 | 2011 | 25 | 0.100 |
Why?
|
Cell Nucleus | 2 | 2013 | 597 | 0.100 |
Why?
|
Immunoblotting | 2 | 2009 | 273 | 0.100 |
Why?
|
Mitochondrial Proteins | 1 | 2012 | 127 | 0.100 |
Why?
|
Middle Aged | 6 | 2021 | 25783 | 0.090 |
Why?
|
Phosphoenolpyruvate Carboxykinase (ATP) | 1 | 2010 | 3 | 0.090 |
Why?
|
Transfection | 2 | 2009 | 911 | 0.090 |
Why?
|
Calorimetry, Indirect | 1 | 2010 | 14 | 0.090 |
Why?
|
Receptors, Calcitriol | 1 | 2011 | 130 | 0.090 |
Why?
|
Sympathetic Nervous System | 1 | 2010 | 94 | 0.090 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2010 | 68 | 0.090 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2010 | 77 | 0.090 |
Why?
|
Immunohistochemistry | 3 | 2016 | 1796 | 0.090 |
Why?
|
Food Industry | 1 | 2010 | 2 | 0.090 |
Why?
|
Phthalic Acids | 1 | 2009 | 4 | 0.090 |
Why?
|
Endrin | 1 | 2009 | 2 | 0.090 |
Why?
|
Estrogens, Non-Steroidal | 1 | 2009 | 30 | 0.090 |
Why?
|
Nuclear Proteins | 2 | 2005 | 725 | 0.090 |
Why?
|
Pheochromocytoma | 1 | 1990 | 49 | 0.090 |
Why?
|
Phenols | 1 | 2009 | 41 | 0.090 |
Why?
|
Benzhydryl Compounds | 1 | 2009 | 44 | 0.090 |
Why?
|
Luciferases | 1 | 2009 | 127 | 0.090 |
Why?
|
RNA, Messenger | 2 | 2013 | 2011 | 0.080 |
Why?
|
Blood Proteins | 1 | 2009 | 145 | 0.080 |
Why?
|
Blood Glucose | 1 | 2013 | 836 | 0.080 |
Why?
|
Genes, Reporter | 1 | 2009 | 274 | 0.080 |
Why?
|
Prednisone | 1 | 2009 | 258 | 0.080 |
Why?
|
Lipogenesis | 3 | 2013 | 23 | 0.080 |
Why?
|
Body Weight | 1 | 2010 | 452 | 0.080 |
Why?
|
RNA Interference | 2 | 2007 | 376 | 0.080 |
Why?
|
Mutation, Missense | 1 | 2010 | 277 | 0.080 |
Why?
|
Prognosis | 1 | 2016 | 3756 | 0.080 |
Why?
|
Genetic Vectors | 1 | 2010 | 446 | 0.080 |
Why?
|
Magnetic Resonance Imaging | 2 | 2018 | 3441 | 0.080 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2007 | 217 | 0.080 |
Why?
|
Health Policy | 1 | 2010 | 184 | 0.080 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2009 | 142 | 0.080 |
Why?
|
Environment | 1 | 2009 | 224 | 0.080 |
Why?
|
Cattle | 2 | 2002 | 375 | 0.080 |
Why?
|
Radiopharmaceuticals | 1 | 2009 | 193 | 0.070 |
Why?
|
Microbiota | 1 | 2013 | 398 | 0.070 |
Why?
|
Tumor Burden | 2 | 2020 | 308 | 0.070 |
Why?
|
Sensitivity and Specificity | 2 | 2009 | 2012 | 0.070 |
Why?
|
Pyruvic Acid | 1 | 2007 | 12 | 0.070 |
Why?
|
Mice, Knockout | 3 | 2021 | 1990 | 0.070 |
Why?
|
Lipids | 1 | 2008 | 271 | 0.070 |
Why?
|
Phosphorylase a | 1 | 2006 | 1 | 0.070 |
Why?
|
Mice, Inbred Strains | 1 | 2006 | 308 | 0.070 |
Why?
|
1,4-alpha-Glucan Branching Enzyme | 1 | 2006 | 1 | 0.070 |
Why?
|
ROC Curve | 1 | 2009 | 778 | 0.070 |
Why?
|
Glycogen Debranching Enzyme System | 1 | 2006 | 3 | 0.070 |
Why?
|
Sleep | 1 | 2010 | 450 | 0.070 |
Why?
|
Glucose Transporter Type 4 | 1 | 2006 | 17 | 0.070 |
Why?
|
Kinetics | 2 | 2003 | 1527 | 0.070 |
Why?
|
Tumor Cells, Cultured | 2 | 2003 | 1057 | 0.070 |
Why?
|
Adenoma | 1 | 2008 | 246 | 0.070 |
Why?
|
Phenotype | 2 | 2020 | 2438 | 0.070 |
Why?
|
Glucose Transporter Type 1 | 1 | 2006 | 20 | 0.070 |
Why?
|
Pyrones | 1 | 2005 | 8 | 0.070 |
Why?
|
RNA | 1 | 2010 | 578 | 0.070 |
Why?
|
Radiographic Image Enhancement | 1 | 2008 | 463 | 0.070 |
Why?
|
Vanadates | 1 | 2005 | 32 | 0.070 |
Why?
|
Solutions | 1 | 2005 | 85 | 0.070 |
Why?
|
Repressor Proteins | 2 | 2009 | 423 | 0.060 |
Why?
|
Genetic Testing | 1 | 2009 | 537 | 0.060 |
Why?
|
Cell Proliferation | 3 | 2018 | 1649 | 0.060 |
Why?
|
Membrane Proteins | 1 | 2012 | 1214 | 0.060 |
Why?
|
Glucokinase | 2 | 2004 | 61 | 0.060 |
Why?
|
Melanocytes | 1 | 2005 | 57 | 0.060 |
Why?
|
Aged, 80 and over | 3 | 2015 | 6757 | 0.060 |
Why?
|
Neural Crest | 1 | 2005 | 32 | 0.060 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2008 | 468 | 0.060 |
Why?
|
Molecular Structure | 1 | 2005 | 288 | 0.060 |
Why?
|
Deoxyglucose | 1 | 2004 | 36 | 0.060 |
Why?
|
Phosphorylases | 1 | 2004 | 4 | 0.060 |
Why?
|
Extracellular Fluid | 1 | 2004 | 25 | 0.060 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2005 | 181 | 0.060 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2009 | 685 | 0.060 |
Why?
|
Drug Synergism | 1 | 2004 | 305 | 0.060 |
Why?
|
Predictive Value of Tests | 1 | 2009 | 1712 | 0.060 |
Why?
|
RNA, Small Interfering | 1 | 2006 | 557 | 0.060 |
Why?
|
Microscopy, Confocal | 1 | 2004 | 276 | 0.060 |
Why?
|
Algorithms | 2 | 2009 | 1870 | 0.060 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2003 | 47 | 0.060 |
Why?
|
Oligomycins | 1 | 2003 | 5 | 0.060 |
Why?
|
Antimycin A | 1 | 2003 | 13 | 0.060 |
Why?
|
Adenylate Kinase | 1 | 2003 | 13 | 0.060 |
Why?
|
Uridine Diphosphate Glucose | 1 | 2003 | 2 | 0.050 |
Why?
|
Protein Phosphatase 2 | 1 | 2003 | 16 | 0.050 |
Why?
|
Indicators and Reagents | 1 | 2003 | 72 | 0.050 |
Why?
|
Methionine | 1 | 2003 | 65 | 0.050 |
Why?
|
Islets of Langerhans | 2 | 2004 | 548 | 0.050 |
Why?
|
Cyclic AMP | 3 | 2004 | 274 | 0.050 |
Why?
|
Appetite | 1 | 2022 | 26 | 0.050 |
Why?
|
Muscle Denervation | 1 | 2002 | 3 | 0.050 |
Why?
|
DNA-Binding Proteins | 2 | 2009 | 1241 | 0.050 |
Why?
|
Ghrelin | 1 | 2022 | 29 | 0.050 |
Why?
|
Substrate Specificity | 1 | 2003 | 351 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 2 | 2005 | 666 | 0.050 |
Why?
|
Cysteine | 1 | 2003 | 136 | 0.050 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2022 | 125 | 0.050 |
Why?
|
Molecular Sequence Data | 1 | 2007 | 3026 | 0.050 |
Why?
|
Rabbits | 1 | 2003 | 637 | 0.050 |
Why?
|
Metabolic Networks and Pathways | 1 | 2022 | 81 | 0.050 |
Why?
|
Electrons | 1 | 2002 | 50 | 0.050 |
Why?
|
Protein Kinase C | 1 | 2002 | 268 | 0.050 |
Why?
|
Trans-Activators | 1 | 2004 | 443 | 0.050 |
Why?
|
Antibodies | 1 | 2003 | 353 | 0.050 |
Why?
|
Retrospective Studies | 2 | 2020 | 8960 | 0.050 |
Why?
|
Biological Transport | 1 | 2002 | 400 | 0.050 |
Why?
|
Models, Chemical | 1 | 2002 | 178 | 0.050 |
Why?
|
Protein Biosynthesis | 1 | 2003 | 388 | 0.050 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2002 | 499 | 0.050 |
Why?
|
Dexamethasone | 2 | 2015 | 344 | 0.050 |
Why?
|
Oxidation-Reduction | 2 | 2012 | 385 | 0.050 |
Why?
|
Germ-Free Life | 1 | 2020 | 75 | 0.050 |
Why?
|
Transforming Growth Factor beta | 1 | 2022 | 321 | 0.050 |
Why?
|
Ohio | 1 | 2020 | 39 | 0.040 |
Why?
|
Transcription, Genetic | 1 | 2005 | 1155 | 0.040 |
Why?
|
Regional Blood Flow | 1 | 2020 | 198 | 0.040 |
Why?
|
Time Factors | 3 | 2004 | 5311 | 0.040 |
Why?
|
Ileum | 1 | 2020 | 160 | 0.040 |
Why?
|
Cell Polarity | 1 | 2020 | 116 | 0.040 |
Why?
|
Metagenomics | 1 | 2020 | 88 | 0.040 |
Why?
|
Enzyme Inhibitors | 1 | 2003 | 645 | 0.040 |
Why?
|
Metagenome | 1 | 2020 | 104 | 0.040 |
Why?
|
Adolescent | 1 | 2012 | 9201 | 0.040 |
Why?
|
Proteins | 1 | 2005 | 786 | 0.040 |
Why?
|
Electron Spin Resonance Spectroscopy | 1 | 2002 | 317 | 0.040 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2020 | 248 | 0.040 |
Why?
|
Organ Size | 1 | 2020 | 368 | 0.040 |
Why?
|
Mitochondria | 1 | 2003 | 551 | 0.040 |
Why?
|
Lipopolysaccharides | 1 | 2020 | 293 | 0.040 |
Why?
|
Colforsin | 2 | 2001 | 74 | 0.040 |
Why?
|
Neoplasm Invasiveness | 1 | 2020 | 575 | 0.040 |
Why?
|
Mice, Mutant Strains | 2 | 2011 | 231 | 0.040 |
Why?
|
Biodiversity | 1 | 2020 | 204 | 0.040 |
Why?
|
Cell Line | 1 | 2003 | 2494 | 0.040 |
Why?
|
Pregnancy Outcome | 1 | 2020 | 253 | 0.040 |
Why?
|
Ligands | 2 | 2013 | 443 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 1 | 2008 | 2647 | 0.040 |
Why?
|
Kidney | 1 | 2003 | 1145 | 0.040 |
Why?
|
Weaning | 1 | 2017 | 25 | 0.040 |
Why?
|
Random Allocation | 1 | 2018 | 328 | 0.040 |
Why?
|
United States | 1 | 2010 | 6928 | 0.040 |
Why?
|
Thiazolidinediones | 2 | 2009 | 73 | 0.040 |
Why?
|
Receptors, Thyroid Hormone | 2 | 2009 | 160 | 0.030 |
Why?
|
Imaging, Three-Dimensional | 1 | 2020 | 595 | 0.030 |
Why?
|
Logistic Models | 1 | 2020 | 1209 | 0.030 |
Why?
|
Prevalence | 1 | 2020 | 1238 | 0.030 |
Why?
|
Culture Media, Conditioned | 1 | 2016 | 103 | 0.030 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2015 | 136 | 0.030 |
Why?
|
Promoter Regions, Genetic | 2 | 2011 | 956 | 0.030 |
Why?
|
Aged | 2 | 2009 | 19014 | 0.030 |
Why?
|
Longitudinal Studies | 1 | 2018 | 1066 | 0.030 |
Why?
|
Receptors, Estrogen | 1 | 2016 | 386 | 0.030 |
Why?
|
Dermatitis, Occupational | 1 | 1993 | 2 | 0.030 |
Why?
|
Rubber | 1 | 1993 | 6 | 0.030 |
Why?
|
Gloves, Surgical | 1 | 1993 | 6 | 0.030 |
Why?
|
Glucose-6-Phosphate | 2 | 2004 | 2 | 0.030 |
Why?
|
Ionomycin | 1 | 1993 | 21 | 0.030 |
Why?
|
Calcimycin | 1 | 1993 | 33 | 0.030 |
Why?
|
Crohn Disease | 1 | 2020 | 756 | 0.030 |
Why?
|
Carbachol | 1 | 1993 | 36 | 0.030 |
Why?
|
Bradykinin | 1 | 1993 | 46 | 0.030 |
Why?
|
Caloric Tests | 1 | 2013 | 6 | 0.030 |
Why?
|
Infant, Newborn | 1 | 2020 | 2464 | 0.030 |
Why?
|
Colitis, Ulcerative | 1 | 2020 | 733 | 0.030 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 1993 | 57 | 0.030 |
Why?
|
Safflower Oil | 1 | 2013 | 7 | 0.030 |
Why?
|
Thionucleotides | 1 | 1993 | 56 | 0.030 |
Why?
|
PC12 Cells | 1 | 1993 | 115 | 0.030 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1993 | 137 | 0.030 |
Why?
|
Gonads | 1 | 2013 | 19 | 0.030 |
Why?
|
Hypersensitivity, Immediate | 1 | 1993 | 63 | 0.030 |
Why?
|
Nursing Staff, Hospital | 1 | 1993 | 42 | 0.030 |
Why?
|
Antigens, Polyomavirus Transforming | 1 | 2013 | 47 | 0.030 |
Why?
|
Calmodulin | 1 | 1993 | 50 | 0.030 |
Why?
|
Epidermal Growth Factor | 1 | 1993 | 117 | 0.030 |
Why?
|
Milk | 1 | 2013 | 53 | 0.030 |
Why?
|
Cytosol | 1 | 1993 | 192 | 0.030 |
Why?
|
Corticosterone | 1 | 2013 | 35 | 0.030 |
Why?
|
Response Elements | 1 | 2013 | 65 | 0.030 |
Why?
|
Food | 1 | 2013 | 89 | 0.030 |
Why?
|
Medical Staff, Hospital | 1 | 1993 | 108 | 0.030 |
Why?
|
Pregnancy | 1 | 2020 | 3002 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 374 | 0.030 |
Why?
|
Sequence Analysis, DNA | 1 | 2015 | 866 | 0.030 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2012 | 64 | 0.020 |
Why?
|
Biological Transport, Active | 1 | 2011 | 102 | 0.020 |
Why?
|
Feces | 1 | 2013 | 327 | 0.020 |
Why?
|
Fatty Liver | 1 | 2012 | 95 | 0.020 |
Why?
|
Oxygen Consumption | 1 | 2012 | 243 | 0.020 |
Why?
|
Insulin-Secreting Cells | 1 | 2014 | 403 | 0.020 |
Why?
|
Organ Specificity | 1 | 2011 | 272 | 0.020 |
Why?
|
Peroxisome Proliferator-Activated Receptors | 1 | 2010 | 7 | 0.020 |
Why?
|
1-Methyl-3-isobutylxanthine | 1 | 1990 | 16 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2013 | 456 | 0.020 |
Why?
|
Elongation Factor 2 Kinase | 1 | 1990 | 7 | 0.020 |
Why?
|
Locomotion | 1 | 2011 | 138 | 0.020 |
Why?
|
Colon | 1 | 2013 | 509 | 0.020 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2010 | 122 | 0.020 |
Why?
|
Computational Biology | 1 | 2013 | 542 | 0.020 |
Why?
|
Bacteria | 1 | 2013 | 471 | 0.020 |
Why?
|
Heterozygote | 1 | 2010 | 373 | 0.020 |
Why?
|
Models, Molecular | 1 | 2013 | 1294 | 0.020 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2009 | 283 | 0.020 |
Why?
|
Plasmids | 1 | 2009 | 291 | 0.020 |
Why?
|
Down-Regulation | 1 | 1990 | 519 | 0.020 |
Why?
|
DNA Primers | 1 | 2009 | 543 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 2009 | 646 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2009 | 338 | 0.020 |
Why?
|
Fibroblasts | 1 | 2010 | 755 | 0.020 |
Why?
|
Apoptosis | 1 | 2013 | 1715 | 0.020 |
Why?
|
Rats, Zucker | 1 | 2006 | 38 | 0.020 |
Why?
|
Receptors, Leptin | 1 | 2006 | 32 | 0.020 |
Why?
|
Wnt3 Protein | 1 | 2005 | 14 | 0.020 |
Why?
|
Wnt1 Protein | 1 | 2005 | 25 | 0.020 |
Why?
|
Wnt3A Protein | 1 | 2005 | 23 | 0.020 |
Why?
|
Wnt-5a Protein | 1 | 2005 | 10 | 0.020 |
Why?
|
Nuclear Receptor Co-Repressor 1 | 1 | 2005 | 23 | 0.020 |
Why?
|
Phosphorylase Kinase | 1 | 2004 | 1 | 0.020 |
Why?
|
Antigens, Differentiation | 1 | 2005 | 141 | 0.020 |
Why?
|
Receptors, Cell Surface | 1 | 2006 | 289 | 0.020 |
Why?
|
Transcription Factors | 1 | 2013 | 1650 | 0.020 |
Why?
|
Wnt Proteins | 1 | 2005 | 130 | 0.020 |
Why?
|
Amides | 1 | 2004 | 53 | 0.020 |
Why?
|
CREB-Binding Protein | 1 | 2004 | 16 | 0.020 |
Why?
|
Gluconates | 1 | 2004 | 13 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2004 | 269 | 0.010 |
Why?
|
Glucagon | 1 | 2004 | 111 | 0.010 |
Why?
|
Second Messenger Systems | 1 | 2004 | 41 | 0.010 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2004 | 68 | 0.010 |
Why?
|
Muscles | 1 | 2004 | 193 | 0.010 |
Why?
|
Cell Lineage | 1 | 2005 | 291 | 0.010 |
Why?
|
Muscle, Smooth | 1 | 2005 | 354 | 0.010 |
Why?
|
Hydrolysis | 1 | 2003 | 141 | 0.010 |
Why?
|
Brain | 1 | 1993 | 2269 | 0.010 |
Why?
|
Hexokinase | 1 | 2002 | 19 | 0.010 |
Why?
|
Indoles | 1 | 2004 | 310 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2004 | 1011 | 0.010 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2002 | 69 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2008 | 2750 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2003 | 740 | 0.010 |
Why?
|
Reference Values | 1 | 2002 | 661 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2005 | 661 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2001 | 312 | 0.010 |
Why?
|
Angioedema | 1 | 1993 | 4 | 0.010 |
Why?
|
Bronchial Spasm | 1 | 1993 | 15 | 0.010 |
Why?
|
Dermatitis, Allergic Contact | 1 | 1993 | 7 | 0.010 |
Why?
|
Anaphylaxis | 1 | 1993 | 33 | 0.010 |
Why?
|
Immunoglobulin E | 1 | 1993 | 145 | 0.010 |
Why?
|
Emergencies | 1 | 1993 | 121 | 0.010 |
Why?
|